TY - JOUR
T1 - Dutch utility weights for the EORTC cancer-specific utility instrument
T2 - the Dutch EORTC QLU-C10D
AU - the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group
AU - Jansen, F.
AU - Verdonck-de Leeuw, I.M.
AU - Gamper, E.
AU - Norman, R.
AU - Holzner, B.
AU - King, M.
AU - Kemmler, G.
AU - on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group
N1 - Funding Information: This study (PI Georg Kemmler) was supported by the European Organisation for Research and Treatment of Cancer Quality of Life Group, Grant No. 001/2018. Publisher Copyright: © 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/7/1
Y1 - 2021/7/1
N2 - © 2021, The Author(s).Purpose: To measure utilities among cancer patients, a cancer-specific utility instrument called the European Organization for Research and Treatment of Cancer (EORTC) QLU-C10D has been developed based on EORTC quality of life core module (QLQ-C30). This study aimed to provide Dutch utility weights for the QLU-C10D. Methods: A cross-sectional valuation study was performed in 1017 participants representative in age and gender of the Dutch general population. The valuation method was a discrete choice experiment containing 960 choice sets, i.e. pairs of QLU-C10D health states, each health state described in terms of the 10 QLU-C10D domains and the duration of that health state. Each participant considered 16 choice sets, choosing their preferred health state from each pair. Utility scores were derived using generalized estimation equation models. Non-monotonic levels were combined. Results: Utility decrements were generated for all 10 QLU-C10D domains, with largest decrements for pain (− 0.242), physical functioning (− 0.228), and role functioning (− 0.149). Non-monotonic levels of emotional functioning, pain, fatigue, sleep problems, and appetite loss were combined. No decrement in utility was seen in case of a little or quite a bit impairment in emotional functioning or a little pain. The mean QLU-C10D utility score of the participants was 0.85 (median = 0.91, interquartile range = 0.82 to 0.96). Conclusion: Dutch utility decrements were generated for the QLU-C10D. These are important for evaluating the cost-utility of new cancer treatments and supportive care interventions. Further insight is warranted into the added value of the QLU-C10D alongside other utility instruments.
AB - © 2021, The Author(s).Purpose: To measure utilities among cancer patients, a cancer-specific utility instrument called the European Organization for Research and Treatment of Cancer (EORTC) QLU-C10D has been developed based on EORTC quality of life core module (QLQ-C30). This study aimed to provide Dutch utility weights for the QLU-C10D. Methods: A cross-sectional valuation study was performed in 1017 participants representative in age and gender of the Dutch general population. The valuation method was a discrete choice experiment containing 960 choice sets, i.e. pairs of QLU-C10D health states, each health state described in terms of the 10 QLU-C10D domains and the duration of that health state. Each participant considered 16 choice sets, choosing their preferred health state from each pair. Utility scores were derived using generalized estimation equation models. Non-monotonic levels were combined. Results: Utility decrements were generated for all 10 QLU-C10D domains, with largest decrements for pain (− 0.242), physical functioning (− 0.228), and role functioning (− 0.149). Non-monotonic levels of emotional functioning, pain, fatigue, sleep problems, and appetite loss were combined. No decrement in utility was seen in case of a little or quite a bit impairment in emotional functioning or a little pain. The mean QLU-C10D utility score of the participants was 0.85 (median = 0.91, interquartile range = 0.82 to 0.96). Conclusion: Dutch utility decrements were generated for the QLU-C10D. These are important for evaluating the cost-utility of new cancer treatments and supportive care interventions. Further insight is warranted into the added value of the QLU-C10D alongside other utility instruments.
KW - Cancer
KW - Discrete choice experiment
KW - Quality of life
KW - Utility
UR - http://www.scopus.com/inward/record.url?scp=85100558912&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s11136-021-02767-8
DO - https://doi.org/10.1007/s11136-021-02767-8
M3 - Article
C2 - 33512653
SN - 0962-9343
VL - 30
SP - 2009
EP - 2019
JO - Quality of life research
JF - Quality of life research
IS - 7
ER -
